Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 116Unknown 25Recruiting 24Terminated 23Active not recruiting 17Withdrawn 9Not yet recruiting 4Enrolling by invitation 4Suspended 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Neoplasms 40Breast Neoplasms 40Prostatic Neoplasms 24Colorectal Neoplasms 24Uterine Cervical Neoplasms 16Carcinoma, Non-Small-Cell Lung 14Anxiety Disorders 13Stomach Neoplasms 9Lymphoma, Follicular 9Lung Neoplasms 9Leukemia, Myeloid, Acute 9Carcinoma, Hepatocellular 8Brain Neoplasms 8Urinary Bladder Neoplasms 7Sarcoma 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Head and Neck Neoplasms 7Esophageal Squamous Cell Carcinoma 7Esophageal Neoplasms 7Ovarian Neoplasms 6Epilepsy 6Depression 6Colonic Neoplasms 6Uterine Cervical Dysplasia 5Small Cell Lung Carcinoma 5Pain 5Glioma 5Dementia 5Cholangiocarcinoma 5Recurrence 4

Interventions

130-nm albumin-bound paclitaxel 2camrelizumab 1anlotinib 1S 1 (combination) 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Enrolling by invitation × Interventional × Gallbladder Neoplasms × Clear all
NCT07310069 2025-12-30

TRANSFORM-GBC

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2 Enrolling by invitation
44 enrolled
Gastrointestinal

Gallbladder Neoplasms

NCT06963060 2025-05-08

GALENT-BT

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2 Enrolling by invitation
44 enrolled
Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma

NCT06901622 2025-03-30

Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma

The First Affiliated Hospital of Zhengzhou University

Phase 2 Enrolling by invitation
50 enrolled
Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma

NCT06671418 2024-11-04

TESLA RCT

Erasmus Medical Center

Phase 3 Enrolling by invitation
148 enrolled
Gastrointestinal

Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡